SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-057797
Filing Date
2019-10-30
Accepted
2019-10-30 16:06:11
Documents
3
Period of Report
2019-10-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-20831_28k.htm 8-K 28993
2 EX-99.1 a19-20831_2ex99d1.htm EX-99.1 11642
3 GRAPHIC g208312mmi001.jpg GRAPHIC 4471
  Complete submission text file 0001104659-19-057797.txt   48281
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 191180019
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Office of Life Sciences